Handmade quality · Free shipping over $75 · Explore the atelier

Pomalidomide-PEG4-Ph-NH2 Catalog No.:M13003-10 PF-06882961 potentiates glucose-stimulated insulin release

SKU: 24162113008

4.4
USD120.00 USD148.00

Pay in 4 interest-free payments of $30.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

PF-06882961 potentiates glucose-stimulated insulin release and reduces food intake in monkeys

[1-3] VX-745 (60 nM-20 µM) inhibits IL-6 and VEGF secretion in bone marrow stromal cells (BMSCs)

The proliferative responses of allogeneic CD4(+) T cells to Suplatast tosilate-treated DCs are suppressed

SLV313 had full agonist activity at cloned h5-HT(1A) receptors (pEC(50)=9

Pomalidomide-PEG4-Ph-NH2 Catalog No.:M13003-10 PF-06882961 potentiates glucose-stimulated insulin releasePomalidomide PEG4 Ph NH2 is a synthesized E3 ligase ligand linker conjugate that incorporates the Pomalidomide based cereblon ligand and 4 unit PEG linker used in PROTAC technology. Product information CAS Number: 1818885 63 0 Molecular Weight: 540. 56 Formula: C27H32N4O8 Chemical Name: 4 [12 (4 aminophenoxy) 4,7,10 trioxa 1 azadodecan 1 yl] 2 (2,6 dioxopiperidin 3 yl) 2,3 dihydro 1H isoindole 1,3 dione Smiles:

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products